EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of M6A LncRNA Modification in Papillary Thyroid Cancer

Michelle S Klausner iD, Caylee A Greenberg iD, Kaleb A Noruzi, Raj K Tiwari, Jan Geliebter iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26072833 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Michelle S Klausner und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, New York Medical College, Valhalla, NY 10595, USA. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenosine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Touro Student Research Fellowship, New York State Empire Clinical Research Investigator Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyroid Cancer (TC) is the most common endocrine cancer, of which papillary thyroid cancer (PTC), a well-differentiated type of TC, accounts for 80–90%. Long non-coding RNAs (lncRNAs), which comprise non-protein-coding segments of the genome, have been found to play a crucial role in various biological processes, including cancer development. The activity of lncRNAs is modified through epigenetic modifications, with N6-Methyladenosine (m6A) modifications implicated in the progression of several malignancies. The activity of m6A is further regulated by modifying enzymes classified as “readers”, writers”, and “erasers”, of which specific enzymes have been found to play a role in various aspects of PTC. Recent research has highlighted the significance of m6A modification in regulating the expression and function of lncRNAs associated with PTC pathogenesis. Dysregulation of this process implicates tumor proliferation, invasion, and metastasis, with subsequent impact on prognosis. Therefore, understanding the interplay between m6A modification and lncRNAs provides valuable insights into the molecular mechanisms underlying PTC progression. This narrative review aims to explore the established role of several prominent m6A modifying enzymes and lncRNAs on cancer pathogenesis and seeks to clarify the function of these enzymes in PTC pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingThyroid Cancer, PapillaryThyroid NeoplasmsAdenosineHumansGene Expression Regulation, NeoplasticEpigenesis, GeneticAnimals

Stichwörter der Autor:innen

LncRNAN6-methyladenosinecancer pathogenesisepigeneticsm6A modificationpapillary thyroid cancerthyroid cancer

Substanzen

RNA, Long NoncodingN-methyladenosineAdenosine

Autor:innen und Institutionen

  • School of Medicine, New York Medical College, Valhalla, NY 10595, USA.
  • Department of Pathology, Microbiology, and Immunology, and Department of Otolaryngology, New York Medical College, Valhalla, NY 10595, USA.

ORCID-Profile: Michelle S Klausner, Caylee A Greenberg, Jan Geliebter

Förderung

  • Touro Student Research Fellowship
  • New York State Empire Clinical Research Investigator Program

Zitieren

APA

Klausner, M. S., Greenberg, C. A., Noruzi, K. A., Tiwari, R. K., & Geliebter, J. (2025). The Role of M6A LncRNA Modification in Papillary Thyroid Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26072833

Vancouver

Klausner MS, Greenberg CA, Noruzi KA, Tiwari RK, Geliebter J. The Role of M6A LncRNA Modification in Papillary Thyroid Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26072833

BibTeX
@article{Klausner2025,
  author = {Klausner, Michelle S and Greenberg, Caylee A and Noruzi, Kaleb A and Tiwari, Raj K and Geliebter, Jan},
  title = {The Role of M6A LncRNA Modification in Papillary Thyroid Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26072833}
}
Kostenlos starten →